Masimo Corporation 0JZ2.L Stock
Masimo Corporation Price Chart
Masimo Corporation 0JZ2.L Financial and Trading Overview
Masimo Corporation stock price | 137.39 USD |
Previous Close | 161.97 USD |
Open | 0 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0 - 0 USD |
52 Week Range | 0 - 197.07 USD |
Volume | 0 USD |
Avg. Volume | 206 USD |
Market Cap | 85.38M USD |
Beta (5Y Monthly) | 0.869718 |
PE Ratio (TTM) | 0.41451824 |
EPS (TTM) | 3.87 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
0JZ2.L Valuation Measures
Enterprise Value | 9.58B USD |
Trailing P/E | 0.41451824 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.037175074 |
Price/Book (mrq) | 6.3661976 |
Enterprise Value/Revenue | 4.171 |
Enterprise Value/EBITDA | 27.306 |
Trading Information
Masimo Corporation Stock Price History
Beta (5Y Monthly) | 0.869718 |
52-Week Change | 30.84% |
S&P500 52-Week Change | 20.43% |
52 Week High | 197.07 USD |
52 Week Low | 0 USD |
50-Day Moving Average | 176.33 USD |
200-Day Moving Average | 157.84 USD |
0JZ2.L Share Statistics
Avg. Volume (3 month) | 206 USD |
Avg. Daily Volume (10-Days) | 61 USD |
Shares Outstanding | 53M |
Float | 44.48M |
Short Ratio | N/A |
% Held by Insiders | 8.27% |
% Held by Institutions | 86.03% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | April 1, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 5.14% |
Operating Margin (ttm) | 8.92% |
Gross Margin | 49.59% |
EBITDA Margin | 15.27% |
Management Effectiveness
Return on Assets (ttm) | 5.09% |
Return on Equity (ttm) | 8.11% |
Income Statement
Revenue (ttm) | 2.3B USD |
Revenue Per Share (ttm) | 43.41 USD |
Quarterly Revenue Growth (yoy) | 85.70% |
Gross Profit (ttm) | 1.06B USD |
EBITDA | 350.8M USD |
Net Income Avi to Common (ttm) | 118.2M USD |
Diluted EPS (ttm) | 3.871 |
Quarterly Earnings Growth (yoy) | -54.30% |
Balance Sheet
Total Cash (mrq) | 174.1M USD |
Total Cash Per Share (mrq) | 3.3 USD |
Total Debt (mrq) | 1.01B USD |
Total Debt/Equity (mrq) | 75.72 USD |
Current Ratio (mrq) | 2.162 |
Book Value Per Share (mrq) | 25.205 |
Cash Flow Statement
Operating Cash Flow (ttm) | 6.6M USD |
Levered Free Cash Flow (ttm) | -47275000 USD |
Profile of Masimo Corporation
Country | United Kingdom |
State | CA |
City | Irvine |
Address | 52 Discovery |
ZIP | 92618 |
Phone | 949 297 7000 |
Website | https://www.masimo.com |
Industry | |
Sector(s) | |
Full Time Employees | 4000 |
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and O3 regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Patient SafetyNet Surveillance, SafetyNet, SafetyNet-Open, Replica, Iris, MyView, UniView, Uniview: 60, Trace, Masimo Sleep, Centroid, and Bridg; and nasal high-flow ventilation, neuromodulation therapeutics, and telehealth solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Q&A For Masimo Corporation Stock
What is a current 0JZ2.L stock price?
Masimo Corporation 0JZ2.L stock price today per share is 137.39 USD.
How to purchase Masimo Corporation stock?
You can buy 0JZ2.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Masimo Corporation?
The stock symbol or ticker of Masimo Corporation is 0JZ2.L.
How many shares does Masimo Corporation have in circulation?
The max supply of Masimo Corporation shares is 532.07K.
What is Masimo Corporation Price to Earnings Ratio (PE Ratio)?
Masimo Corporation PE Ratio is 0.35492120 now.
What was Masimo Corporation earnings per share over the trailing 12 months (TTM)?
Masimo Corporation EPS is 3.87 USD over the trailing 12 months.